COMMUNIQUÉS West-GlobeNewswire

Nicox annonce l’extension de son horizon de trésorerie
02/09/2026
Communiqué de presse Nicox annonce l’extension de son horizon de trésorerie Position de trésorerie de 8.4 millions d’euros 1 au 31 août 2026 , suffisante pour financer les opérations actuelles au-delà du 1er trimestre [...]
IBA joins PFAROS European initiative to advance PFAS destruction for healthcare and pharmaceutical applications
02/09/2026
Louvain-la-Neuve, Belgium, 2 September 2026, 7 a.m. – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces its participation in PFAROS, a new European research [...]
IBA rejoint l’initiative européenne PFAROS pour accélérer le développement de solutions de destruction des PFAS dans les secteurs de la santé et de la pharmacie
02/09/2026
Louvain ‑ la ‑ Neuve, Belgique, le 2 septembre 2026, 7h00 – IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélérateurs de particules, annonce aujourd’hui sa participation à PFAROS, [...]
Desert Hope Treatment Center Addresses Community Need for Increased Addiction Services with New Virtual Program
02/09/2026
LAS VEGAS, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Desert Hope Treatment Center, a leading addiction treatment provider in Las Vegas, has added a virtual intensive outpatient treatment program to its array of care services. [...]
Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway
02/09/2026
The Phase 3 BiPASS™ study of Illuccix® and Gozellix® for prostate cancer imaging in the pre-biopsy setting has completed enrollment of 350 patients. Telix has positively engaged with the FDA on a New Drug Application ( [...]
Pennant Group to Participate in the 2026 Jefferies Healthcare Services Conference
02/09/2026
EAGLE, Idaho, Sept. 01, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it [...]
HWH International Inc. Announces Executive Leadership Transition
01/09/2026
BETHESDA, MD, Sept. 01, 2026 (GLOBE NEWSWIRE) -- HWH International Inc. (Nasdaq: HWH) ("HWH" or the "Company") today announced a transition in its executive leadership. Chan Heng Fai (“ Mr. Chan ”), the Company's [...]
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/09/2026
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib [...]
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
01/09/2026
CAMBRIDGE, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients [...]
aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
01/09/2026
Company anticipates response from FDA by mid-September 2026 on protocol submitted for planned Phase 3 study of efzofitimod in patients with pulmonary sarcoidosis with restrictive lung disease. SAN DIEGO, Sept. 01, 2026 [...]
STERIS to Present at the Morgan Stanley Healthcare Conference
01/09/2026
Dublin, Ireland, Sept. 01, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will participate in the Morgan Stanley Healthcare Conference in New York City on Tuesday, [...]
Cellectis Announces Participation in Upcoming Investor Conferences
01/09/2026
NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving [...]
Cellectis annonce sa participation à plusieurs conférences investisseurs
01/09/2026
NEW YORK, 01 sept. 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS ; Nasdaq : CLLS), société de biotechnologie de stade clinique, qui utilise sa plateforme pionnière d'édition de génome pour développer des [...]
Teva to Present at Morgan Stanley, J.P. Morgan and BofA Investor Conferences in September
01/09/2026
TEL AVIV, Israel, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at three upcoming investor [...]
Tarsus to Participate in Upcoming Investor Conferences
01/09/2026
IRVINE, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to attend the following upcoming investor conferences: Wells Fargo 21 st Annual [...]
Braveheart Bio to Participate in Cantor Global Healthcare Conference
01/09/2026
SAN FRANCISCO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Braveheart Bio, Inc. (Nasdaq: BRVE), a clinical-stage biopharmaceutical company developing next-generation therapeutics for hypertrophic cardiomyopathy (HCM) and other [...]
Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01/09/2026
BOSTON, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA) (“Aura” or the “Company”), a clinical-stage biotechnology company developing a potentially transformative first-in-class therapy for [...]
Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference
01/09/2026
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, today announced that Chris [...]
LifeStance to Present at Upcoming Investor Conferences
01/09/2026
SCOTTSDALE, Ariz., Sept. 01, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced that management will present at [...]

Pages